EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
- |
Priestia megaterium |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
- |
Lysinibacillus sphaericus |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
- |
Bacillus cereus |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
- |
Corynebacterium glutamicum |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
- |
Mycobacterium tuberculosis |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
- |
Thermotoga maritima |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
highest activity during exponential growth phase |
Brevibacillus brevis |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
highest activity during exponential growth phase |
Lysinibacillus sphaericus |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
no regulatory effect of lysine |
Brevibacillus brevis |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |
1.17.1.8 | 2,3-dihydrodipicolinate + NAD(P)H |
lysine and diaminopimelate biosynthesis pathway |
Escherichia coli |
2,3,4,5-tetrahydrodipicolinate + NAD(P)+ |
- |
? |